Literature DB >> 15305338

Therapeutic activity of 3,3'-diindolylmethane on prostate cancer in an in vivo model.

Maya Nachshon-Kedmi1, Fuad A Fares, Shmuel Yannai.   

Abstract

BACKGROUND: Prostate cancer (PC) is the second leading cancer-related death in men in Western countries. Hence, efficient anti-carcinogenic and therapeutic compounds against PC are badly needed. We have previously shown that 3,3'-diindolylmethane (DIM) has a suppressive effect on the growth of human breast and PC cell lines. The objective of this study was examination of the potential therapeutic effects of DIM in an in vivo model.
METHODS: TRAMP-C2, a mouse PC cell line, was injected into the flank of male C57BL/6 mice. When tumors appeared, mice were injected intraperitoneally with either corn oil (vehicle) or DIM (2.5, 5, or 10 mg per kg body weight) 3-times a week, for 3 weeks, and tumor volumes were measured bi-weekly with calibermeters. Later, the tumors were removed, their final weights and volumes were measured, and tumor sections were tested for histological studies.
RESULTS: DIM had a significant inhibitory effect, caused by diminished tumor growth. Histological examination of tumors from treated groups revealed apoptosis and decreased cell proliferation, compared with the controls. DIM didn't affect body weights or kidney and liver functioning.
CONCLUSIONS: The inhibitory action of DIM on tumor growth was demonstrated in vivo. Hence, this compound at the concentrations tested may offer an effective and non toxic therapeutic means against tumor growth in rodents, and may serve as a potential natural anti-carconigenic compound in humans. Copyright 2004 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15305338     DOI: 10.1002/pros.20092

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  27 in total

1.  A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer.

Authors:  Elisabeth I Heath; Lance K Heilbrun; Jing Li; Ulka Vaishampayan; Felicity Harper; Pam Pemberton; Fazlul H Sarkar
Journal:  Am J Transl Res       Date:  2010-07-23       Impact factor: 4.060

2.  DIM (3,3'-diindolylmethane) confers protection against ionizing radiation by a unique mechanism.

Authors:  Saijun Fan; Qinghui Meng; Jiaying Xu; Yang Jiao; Lin Zhao; Xiaodong Zhang; Fazlul H Sarkar; Milton L Brown; Anatoly Dritschilo; Eliot M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-14       Impact factor: 11.205

Review 3.  Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics.

Authors:  Fazlul H Sarkar; Yiwei Li
Journal:  Cancer Treat Rev       Date:  2009-08-05       Impact factor: 12.111

4.  3,3'-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells.

Authors:  Laura M Beaver; Tian-Wei Yu; Elizabeth I Sokolowski; David E Williams; Roderick H Dashwood; Emily Ho
Journal:  Toxicol Appl Pharmacol       Date:  2012-07-16       Impact factor: 4.219

5.  Pharmacokinetic evaluation and in vitro-in vivo correlation (IVIVC) of novel methylene-substituted 3,3' diindolylmethane (DIM).

Authors:  Apurva R Patel; Shawn D Spencer; Mahavir B Chougule; Stephen Safe; Mandip Singh
Journal:  Eur J Pharm Sci       Date:  2012-02-08       Impact factor: 4.384

Review 6.  Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic.

Authors:  Sanjeev Banerjee; Dejuan Kong; Zhiwei Wang; Bin Bao; Gilda G Hillman; Fazlul H Sarkar
Journal:  Mutat Res       Date:  2011-06-15       Impact factor: 2.433

7.  Inhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myo-inositol in A/J mice.

Authors:  Fekadu Kassie; Stephen Kalscheuer; Ilze Matise; Linan Ma; Tamene Melkamu; Pramod Upadhyaya; Stephen S Hecht
Journal:  Carcinogenesis       Date:  2009-07-22       Impact factor: 4.944

8.  Down-regulation of uPA and uPAR by 3,3'-diindolylmethane contributes to the inhibition of cell growth and migration of breast cancer cells.

Authors:  Aamir Ahmad; Dejuan Kong; Zhiwei Wang; Sanila H Sarkar; Sanjeev Banerjee; Fazlul H Sarkar
Journal:  J Cell Biochem       Date:  2009-11-01       Impact factor: 4.429

9.  Ring-substituted analogs of 3,3'-diindolylmethane (DIM) induce apoptosis and necrosis in androgen-dependent and -independent prostate cancer cells.

Authors:  A A Goldberg; V I Titorenko; A Beach; K Abdelbaqi; S Safe; J T Sanderson
Journal:  Invest New Drugs       Date:  2013-05-25       Impact factor: 3.850

10.  Induction of G1 and G2/M cell cycle arrests by the dietary compound 3,3'-diindolylmethane in HT-29 human colon cancer cells.

Authors:  Hyun Ju Choi; Do Young Lim; Jung Han Yoon Park
Journal:  BMC Gastroenterol       Date:  2009-05-29       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.